Covered recipient · General Payments record
CHARLES OSHINSKY
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$4,931.80
- Reported across 27 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,832.50 | 2 |
| Travel and Lodging | $790.65 | 2 |
| Food and Beverage | $681.68 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SOBI, INC | $2,582.76 | 3 |
| ABBVIE INC. | $1,347.96 | 11 |
| Amgen Inc. | $203.44 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $146.44 | 2 |
| Organon LLC | $24.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $223.44 | 05/02/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1105160625 | CMS |
| ABBVIE INC. | $19.13 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105160627 | CMS |
| ABBVIE INC. | $38.26 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105160629 | CMS |
| ABBVIE INC. | $47.83 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105160631 | CMS |
| ABBVIE INC. | $567.21 | 05/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1105160633 | CMS |
| ABBVIE INC. | $8.55 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105160635 | CMS |
| ABBVIE INC. | $8.71 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105160637 | CMS |
| ABBVIE INC. | $4.83 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105160639 | CMS |
| ABBVIE INC. | $4.46 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105160641 | CMS |
| ABBVIE INC. | $0.54 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105160643 | CMS |
| ABBVIE INC. | $425.00 | 11/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105160645 | CMS |
| Amgen Inc. | $116.10 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111667038 | CMS |
| Amgen Inc. | $87.34 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111667036 | CMS |
| Novartis Pharmaceuticals Corporation | $139.86 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087343067 | CMS |
| Novartis Pharmaceuticals Corporation | $6.58 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087343085 | CMS |
| Organon Llc | $24.23 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136227666 | CMS |
| SOBI, INC | $50.25 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141411346 | CMS |
| SOBI, INC | $125.01 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141412324 | CMS |
| SOBI, INC | $2,407.50 | 11/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141423675 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.